3D Medicines (HKSE:01244) Days Payable : 481.87 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is 3D Medicines Days Payable?

3D Medicines's average Accounts Payable for the six months ended in Dec. 2023 was HK$62.9 Mil. 3D Medicines's Cost of Goods Sold for the six months ended in Dec. 2023 was HK$23.8 Mil. Hence, 3D Medicines's Days Payable for the six months ended in Dec. 2023 was 481.87.

The historical rank and industry rank for 3D Medicines's Days Payable or its related term are showing as below:

HKSE:01244' s Days Payable Range Over the Past 10 Years
Min: 86.39 Med: 259.48 Max: 327.56
Current: 325.37

During the past 4 years, 3D Medicines's highest Days Payable was 327.56. The lowest was 86.39. And the median was 259.48.

HKSE:01244's Days Payable is ranked better than
70.1% of 719 companies
in the Biotechnology industry
Industry Median: 147.29 vs HKSE:01244: 325.37

3D Medicines's Days Payable increased from Dec. 2022 (107.29) to Dec. 2023 (481.87). It may suggest that 3D Medicines delayed paying its suppliers.

3D Medicines Days Payable Historical Data

The historical data trend for 3D Medicines's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3D Medicines Days Payable Chart

3D Medicines Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Days Payable

259.48

86.39

327.56

3D Medicines Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial			-	46.92	107.29	198.48	481.87

Competitive Comparison of 3D Medicines's Days Payable

For the Biotechnology subindustry, 3D Medicines's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

3D Medicines's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3D Medicines's Days Payable distribution charts can be found below:

* The bar in red indicates where 3D Medicines's Days Payable falls into.

3D Medicines Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

3D Medicines's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (17.733	+	78.642)	/	2 )	/	53.695	*	365
=	48.1875					/	53.695	*	365
=	327.56

3D Medicines's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (47.221	+	78.642)	/	2 )	/	23.834	*	365 / 2
=	62.9315					/	23.834	*	365 / 2
=	481.87

3D Medicines Days Payable Related Terms

Thank you for viewing the detailed overview of 3D Medicines's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

3D Medicines (HKSE:01244) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3D Medicines Inc (HKSE:01244) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3 and No. 5, Laiyang Road, Shandong, Qingdao, CHN

Website

https://www.3d-medicines.com

3D Medicines Inc is a commercial-stage biopharmaceutical company that researches, develops, and commercialization of drugs in the field of managing cancer as a chronic disease. It develops differentiated immuno-oncology drugs, helping cancer patients live with prolonged survival time and quality of life.

3D Medicines (HKSE:01244) Headlines

No Headlines